JPS5294430A - Medical composition for surpressing secretion of stomach juice as polypeptide main ingredient - Google Patents

Medical composition for surpressing secretion of stomach juice as polypeptide main ingredient

Info

Publication number
JPS5294430A
JPS5294430A JP578276A JP578276A JPS5294430A JP S5294430 A JPS5294430 A JP S5294430A JP 578276 A JP578276 A JP 578276A JP 578276 A JP578276 A JP 578276A JP S5294430 A JPS5294430 A JP S5294430A
Authority
JP
Japan
Prior art keywords
surpressing
secretion
main ingredient
medical composition
stomach juice
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP578276A
Other languages
Japanese (ja)
Other versions
JPS6037090B2 (en
Inventor
Maagaretsuto Puresuton Beriru
Guregorii Hararudo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Imperial Chemical Industries Ltd
Original Assignee
Imperial Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Chemical Industries Ltd filed Critical Imperial Chemical Industries Ltd
Priority to JP51005782A priority Critical patent/JPS6037090B2/en
Publication of JPS5294430A publication Critical patent/JPS5294430A/en
Publication of JPS6037090B2 publication Critical patent/JPS6037090B2/en
Expired legal-status Critical Current

Links

Landscapes

  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
JP51005782A 1976-01-21 1976-01-21 Polypeptide and a pharmaceutical composition containing this polypeptide as a main component that suppresses the secretion of acidic gastric juice Expired JPS6037090B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP51005782A JPS6037090B2 (en) 1976-01-21 1976-01-21 Polypeptide and a pharmaceutical composition containing this polypeptide as a main component that suppresses the secretion of acidic gastric juice

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP51005782A JPS6037090B2 (en) 1976-01-21 1976-01-21 Polypeptide and a pharmaceutical composition containing this polypeptide as a main component that suppresses the secretion of acidic gastric juice

Publications (2)

Publication Number Publication Date
JPS5294430A true JPS5294430A (en) 1977-08-09
JPS6037090B2 JPS6037090B2 (en) 1985-08-24

Family

ID=11620670

Family Applications (1)

Application Number Title Priority Date Filing Date
JP51005782A Expired JPS6037090B2 (en) 1976-01-21 1976-01-21 Polypeptide and a pharmaceutical composition containing this polypeptide as a main component that suppresses the secretion of acidic gastric juice

Country Status (1)

Country Link
JP (1) JPS6037090B2 (en)

Also Published As

Publication number Publication date
JPS6037090B2 (en) 1985-08-24

Similar Documents

Publication Publication Date Title
DE2960293D1 (en) Substituted pyridylsulfinylbenzimidazoles having gastric acid secretion properties, pharmaceutical preparations containing same, and intermediates for their preparation
JPS5283916A (en) Medical composition for aural administration
JPS53147069A (en) Guanidine derivative process for preparing same and pharmaceutical composition for inhibiting positive modifying response and inhibiting secretion of gastric acid
GB2101482B (en) Pharmaceutical composition for the treatment of diabetes mellitus
JPS5579321A (en) Medical composition for local administration
GB2113089B (en) Inhibiting the secretion of stomach acid
IL50047A (en) Somatostatin analogs,their preparation and pharmaceutical compositions containing them
JPS579721A (en) Medicinal composition for treatment of youth diabetes mellitus
JPS5746950A (en) Peptide, manufacture of same and medicinal composition containing same
JPS549282A (en) Novel aminopiperidines*its preparation*and medical compositions
GB1550473A (en) Suppressing gastric acid secretion by the oral administration of calcitonin
JPS5215826A (en) Medical composition
CS186285B2 (en) Mode of manufacture of ingredient for ruminant fodder
AR243167A1 (en) Substituted toluidines, process for their preparation, pharmaceutical compositions containing them and their use as gastric secretion inhibitors
IL56150A (en) Polypeptides having the ability to induce the differentiation of t-and b-lymphocytes,their manufacture and pharmaceutical compositions containing them
JPS5294430A (en) Medical composition for surpressing secretion of stomach juice as polypeptide main ingredient
JPS57165373A (en) Guanidine derivative, manufacture and medicinal composition containing same for gastric acid secretion inhibition
JPS527419A (en) Heterocolloidal deblicin containing medical composition and its preparation
JPS5321160A (en) Novel 55thiazolealkylamine derivative* its preparation and medical composition
ZA745981B (en) Medicinal composition for the oral treatment of diabetes
JPS5290633A (en) Polypeptide and medical composition for suppressing secretion of acidic stomach juice containing same as main ingredient
JPS5221312A (en) Reversible powder to medical composition for aural administration
JPS5264193A (en) Mattress for patients
JPS51118840A (en) 33*2*55dihydroxyphenyl**alanine as heart medicine
IL56613A0 (en) Carboxylates of 3-oxo-androst adienes,their preparation and pharmaceutical compositions containing same